On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...
Patentees and sponsors of New Drug Applications (NDAs ... which permits Teva to market and sell an inhaler device that administers the API albuterol sulfate. Teva listed several patents in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback